1-1 of 1
Michael J. Burke
Close
Sort by
Journal Articles

Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia

Clinical Trials & Observations
Amy K. Keating, Nathan Gossai, Christine L. Phillips, Kelly Maloney, Kristen Campbell, Andrew Doan, Deepa Bhojwani, Michael J. Burke, Michael R. Verneris
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1926–1929.
https://doi.org/10.1182/bloodadvances.2018025726
Published: 2019